Skip to main content
Search form
Search
Subscribe to newsletter +
European Association of Hospital Pharmacists
Menu
Main menu
Home
About Us
Who we are
Board
Staff
Students
Transparency
Contact Information
Call for Expressions of Interest
Members
Associate membership
News
Press Releases
EAHP Newsletters
EAHP in the news
Multimedia Gallery
Events
Calendar
Academy
Synergy Masterclass
EAHP BOOST
Congresses
General Assemblies
Accreditations
EAHP Synergy Certification Courses
Open Learning
Get Involved
Sponsors and partners
HP Practice
EAHP COVID-19 Resource Centre
European Statements of Hospital Pharmacy
What hospital pharmacists do
EAHP-ESCP Oath to Society
FIP global statements
National legislation on hospital pharmacy
Good Practice Initiatives
Common training framework
Environmental Sustainability
European Council for Pharmacy Education Accreditation
Investigation of the hospital pharmacy profession in Europe
Hospital Pharmacy Day
SIGs
Controlled Substances Management
Special Interest Group on Investigation of medication errors and efficiency in oncology
Automated Medication Management
Working Towards Eliminating Avoidable Harm
Hazardous Medicinal Products
Hospital Pharmacist’s Preparedness for in-vivo gene therapy medicinal products
Investigation of Medication Errors in Intensive Care Units
Use of Prefilled Syringes in Intensive Care Units and Operating Theaters
Policy
Resources
Consultations
Position Papers
Get involved and keep up to date
Access to Medicines
Ageing society
Infectious Diseases and AMR
ATMPs
Bar coding medicines to the single unit
Biosimilar medicines
Clinical trials
Digital Health
EMA - EAHP collaboration
European List of Emergency Medicines
Falsified Medicines
Hazardous Medicinal Products
Hospital Pharmacy Specialisation
Medical device regulation
Medicines shortages
Patient safety
Pharmaceuticals in the environment
Pharmacy preparations and compounding
Procurement
Public spending austerity
SmPC
Vaccination
Workforce
Statements
GPIs
Publications
2019 EP Election Manifesto
General information
EAHP Annual report
European Journals of Hospital Pharmacy
EAHP Surveys of HP practice
EAHP History Book
Practical Pharmaceutics
Congress presentation webcasts
2024 European Parliament Election Manifesto
Member Center
You are here
Home
Other Hospital Pharmacy Topics
OHP-002
COST OF TREATMENT ANALYSIS OF BIOSIMILAR AND INNOVATOR INFLIXIMAB IN A TERTIARY LEVEL HOSPITAL
OHP-032
INVOLVEMENT OF PHARMACISTS FROM THE ALPES-MARITIMES FIRE & RESCUE SERVICES (SDIS 06) DURING THE TERRORIST ATTACK OF JULY 14, 2016 IN NICE (FRANCE)
OHP-031
EVOLUTION IN TREATMENT OF MULTIPLE SCLEROSIS IN A MEDIUM SIZED HOSPITAL
OHP-028
RATIONALISATION SCHEME FOR APPROPRIATE CONSUMPTION OF MEDICAL GLOVES IN A GENERAL HOSPITAL
OHP-027
ANTICHOLINERGIC BURDEN CALCULATOR WEB TOOL
OHP-024
CONTROVERSY BETWEEN CYCLIC PARENTERAL NUTRITION AND TOTAL PARENTERAL NUTRITION
OHP-022
EVALUATION OF EFFICACY AND SAFETY OF HEPATITIS C VIRUS TREATMENT WITH THE NEW DIRECT ACTING ANTIVIRALS IN THE CLINICAL PRACTICE OF A REGIONAL HOSPITAL
OHP-018
SINGLE USE CANISTER FREE NEGATIVE PRESSURE WOUND THERAPY (NPWT): AN ALTERNATIVEAN ECONOMICAL ALTERNATIVE
OHP-012
TECHNOLOGY AT THE SERVICE OF THE PHARMACIST: IDEA OF SOFTWARE TO SUPPORT THE 'AGENZIA ITALIANA DEL FARMACO' REGISTERS
OHP-011
LIPID EMULSION BASED EXCLUSIVELY ON OMEGA-3 FATTY ACIDS FOR ABNORMAL LIVER FUNCTIONING ASSOCCIATED WITH TOTAL PARENTERAL NUTRITION AT HOME
OHP-007
PRESCRIPTION OF ORAL SUPPLEMENTS DURING A HOSPITALISATION PERIOD
OHP-003
COST ANALYSIS OF THERAPY FOR PATIENTS WITH MULTIPLE SCLEROSIS THREE YEARS AGO AND NOW
OHP-001
HOSPITAL PHARMACY TECHNICIANS IN FRANCE AND QUEBEC : DIFFERENCES IN TRAINING AND PRACTICE
OHP-013
CORONARY STENTS IN A REGIONAL HOSPITAL: EVOLUTION AND ANALYSIS FROM 2011 TO 2015
OHP-010
ECONOMIC ANALYSIS OF SUBCUTANEOUS TRASTUZUMAB USE VERSUS INTRAVENOUS TRASTUZUMAB
Pages
1
2
3
4
5
next ›
last »
Follow Us